A remarkable degree of genetic variation has been found in the protein-encoding regions of DNA through deep sequencing of samples obtained from thousands of subjects from several populations. Approximately half of the 20 000 single nucleotide polymorphisms present, even in normal healthy subjects, are nonsynonymous amino acid substitutions that could potentially affect protein function. The greatest challenges currently facing investigators are data interpretation and the development of strategies to identify the few gene-coding variants that actually cause or confer susceptibility to disease. A confusing array of options is available to address this problem. Unfortunately, the overall accuracy of these tools at ultraconserved positions is low, and predictions generated by current computational tools may mislead researchers involved in downstream experimental and clinical studies. First, we have presented an updated review of these tools and their primary functionalities, focusing on those that are naturally prone to analyze massive variant sets, to infer some interesting similarities among their results. Additionally, we have evaluated the prediction congruency for real whole-exome sequencing data in a proof-of-concept study on some of these web-based tools.
INTRODUCTION
Although the 'exome' (i.e. the part of the genome formed by exons) represents a small fraction of the entire genome, it is a continuously expanding source of pathogenic mutations. Each of the studies involving exome analysis has generally detected 20 000-30 000 single nucleotide polymorphisms (SNPs), but only 40% of these SNPs translate into amino acid changes [1] ; an even smaller portion, in the order of a few hundreds, are private missense mutations, and fewer still are pathogenic [2] .
From a phenotypic standpoint, the effects of such mutations range from 'complete neutrality' to 'complex disease susceptibility' to 'lethality' [2] , and compilation of sufficient experimental knowledge to verify the effects of these phenotypes is always laborious and time-consuming. This limitation has led to the development of various tools that rely on solved or modeled protein structures, or on information derived from comparative genomics and phylogenetic studies, to provide plausible hypotheses regarding the negative effects of such mutations.
These tools are available both as stand-alone packages and, with increasing frequency, as web-based services. The significant shift in attention toward the World Wide Web is a consequence of the drive toward 'software portability', which is vital for a discipline like bioinformatics, in which many different competencies converge and where the operating systems, hardware architecture and programming languages used are among the most diverse. Conversely, a primary drawback is limitations in the internet bandwidth. Although the internet bandwidth has significantly expanded over recent years, it has still not increased sufficiently, thereby hindering the transfer of large quantities of data and limiting the computation and storage capabilities on servers. Therefore, only a few web tools that can accept and efficiently analyze large variant sets are currently available.
Many researchers have compared the performances of their web-based tools [3] [4] [5] [6] . The results of all these studies indicate that predictions obtained using different tools should be interpreted with caution, as they can be affected by the extreme sensitivity of specific algorithm settings, by the 'training' datasets used and by the availability of supplementary information (e.g. orthologous sequences or gene ontology data). What is certain is that some tools closely correlate with each other, whereas others correlate poorly; therefore, the simultaneous application of two or more tools can yield more reliable results.
Therefore, we have not performed yet another systematic comparison of such predictors; rather, we have reviewed the existing state-of-the-art tools, paying particular attention to those accepting massive variant submissions, and have focused on their peculiar functionalities. We have tested the usage of the most convenient and suitable web tools for massive functional classifications of the variants culled out from whole-exome sequencing (WES) experiments. We have compared their results, not in terms of reliability but rather in terms of general congruency, with those produced by two consensus algorithms and a well-known aggregator. We have then examined the uniformity of their predictions by an ad hoc procedure aimed at quantifying the resulting consensus. Several considerations about the overall process of pathogenicity classification of missense SNPs have also been discussed.
WEB TOOLS FOR MASSIVE FUNCTIONAL PREDICTIONS
PolyPhen-2 [7] and SIFT [8] are decidedly the most highly used predictors. Both tools accept several types of input data, including single FASTA protein sequences, protein accession numbers and genomic coordinates. They rapidly annotate and map input variants to genes and transcripts, and exhaustively classify their pathogenicity. Both resources are available as web-based services, as well as stand-alone software packages.
'PolyPhen-2' is a Bayesian classifier that roots on eight sequence-based and three structure-based predictive features [7] . It calculates a positionspecific independent counts profile for each candidate mutation and qualitatively predicts whether it will be benign, possibly damaging or probably damaging, according to the posterior probability intervals (0, 0.2), (0.2, 0.85) and (0.85, 1), respectively. 'SIFT' is a sequence homology-based algorithm that qualifies amino acid substitutions due to nonsynonymous SNPs [8] . It examines the evolutionary conservation of amino acids, according to which highly conserved sites tend to be intolerant to substitutions, whereas sites with a low degree of conservation confer a greater degree of tolerance [9] . For each candidate mutation, the tool lines up orthologous genes and provides the user the potential to set a median information content threshold for the sequences falling within the alignment region. SIFT predicts that a nonsynonymous variant will be damaging if the calculated score is <0.05; if the score is greater than this value, the variant will be tolerated.
Several valid alternative tools are available for such analyses:
'MutationAssessor' [10] calculates a functional impact score (FIS) for a set of query variants by relying on the evolutionary conservation awareness of the affected amino acids in protein homologs. This software has been tested on polymorphic variants associated with a variety of diseases, particularly on missense mutations found in cancer. The four predicted pathogenicity levels according to the computed FIS are as follows: neutral, low, medium and high. It is currently unavailable as a stand-alone package. The 'Condel' web server [11] is primarily an aggregator of results output by third-party tools. It functions between the user and SIFT, PolyPhen-2 and MutationAssessor, to which it conveys large lists of variants and collects and assembles their results. Subsequently, it infers both a consensus prediction and a score. Condel scripts can be downloaded and run locally as well. The 'CRAVAT' web resource (www.cravat.us) has been mainly thought for the analysis of cancer-related variants. It is based on software like CHASM [12] and accepts variants in the form of lists of chromosomal positions or protein IDs, and predicts their functional significance. Moreover, it allows variants to be prioritized according to the probability that they confer increased fitness to a cancer cell. The 'PROVEAN' web-based [13] tool classifies missense SNPs (and other variant typologies) by a two-step approach consisting of the homologous sequence retrieval and the calculation of amino acid substitution matrix-based score. This resource accepts protein sequences or list of SNP-associated chromosomal positions as possible input.
Similarly, other web-based services forward an input variant list into a set of third-party tools and then collect and present their results, without providing a unique consensus response and score.
'Variant Effect Predictor' (VEP) [14] is provided by Ensembl as a web-based service with Perl scripts and application programming interface (API). It accepts and annotates a set of known or unknown variants with several types of functional information. It is used only for human sequences and uses SIFT and PolyPhen-2 to obtain pathogenicity predictions for protein products. 'SNPnexus' [15] accepts single and batch submissions of variants as dbSNP identifiers or chromosomal coordinates. This tool is designed to simplify and assist in the selection of functionally relevant SNPs for large-scale genotyping studies of multifactorial disorders. It reports a wide range of possible functional consequences from the major gene annotation systems. Furthermore, it bases the output on SIFT predictions (tolerated or damaging) to report the effect of nonsynonymous single amino acid substitutions on protein function. 'wANNOVAR' [16] is a step-by-step analysis portal that helps researchers in SNP prioritization. It provides the most popular functionalities of ANNOVAR [17] online with the aim of helping biologists without any bioinformatics training in taking full advantage of the sequencing data. It assembles a list of SNPs and indels in different data formats and annotates their functional effects on genes, retrieves allele frequencies from public databases, implements a 'variant reduction' protocol to identify a subset of potentially deleterious variants and calculates their predicted functional importance according to the scores precomputed by PolyPhen-2 and SIFT.
'Pupasuite 3' [18] is yet another interactive web-based SNP analysis tool. It allows prioritization of relevant SNPs within a gene, based on several properties of the SNP itself, such as validation status, frequency/population data and putative missense SNPs' functional properties determined with the predictions yielded by 'SNPeffect' [19] . The 'SeattleSeq Annotation' (http://snp.gs. washington.edu/SeattleSeqAnnotation/) server provides a wide array of annotations of known and novel SNPs and indels. The annotations include dbSNP rs ID, NCBI and CCDS gene models, variation functions, protein position, amino acid changes, conservation scores, HapMap frequencies, KEGG pathways, ESP allele counts, microRNAs and clinical and pathogenicity associations. PolyPhen-2 predictions have been reported for most missense SNPs. The 'F-SNP' database [20] provides integrated information about the functional effects of SNPs. It references 16 tools and databases to predict the pathogenicity of SNPs at the splicing, transcriptional, translational and post-translational levels. For each level, a series of tests is executed. For example, Ensembl is used to examine whether a variant falling within coding regions is a nonsense mutation, in which case the SNP is considered to be deleterious. If an SNP is a missense mutation, it is further tested by five different tools (SIFT, PolyPhen, SNPeffect, LS-SNPs [21] and SNPs3D [22] ) to determine whether the nonsynonymous substitution is deleterious. A majority vote concludes the process and helps identify whether the SNP has a potentially deleterious functional impact. The web-based interface enables easy navigation for obtaining information through multiple starting points and exploration routes. Although these functions are interesting, the service has not been updated since August 2007.
Unlike the aforementioned tools, 'EvoD' [23] and 'PON-P' [24] accept multiple submissions as NCBI RefSeq Protein IDs and multi-FASTA protein sequences, respectively. The former is an evolutionary diagnosis (EvoD) method, which considers fundamental evolutionary properties of affected sites and amino acid changes. Thus, this analysis uses measures of the biochemical severity and evolutionary probability of the amino acid change, as well as multilevel taxonomic evolutionary rates and time spans of the position affected, to build a predictive statistical model. The tool classifies mutations as 'neutral' or 'deleterious'; thus, it demonstrates improved diagnosis rates and accuracy with respect to Condel and PolyPhen-2. PON-P is a machine learning-based method that allows submissions such as multi-FASTA protein sequences and variations and output predictions of up to 31 different third-party tools. The program uses results from software and databases such as SIFT, PhD-SNP, PolyPhen-2 and SNAP for default analysis, even if the list of auxiliary programs increases up to 10. Therefore, a user running PON-P obtains the summarized output of all these programs.
WEB-BASED TOOLS FOR ON-THE-FLY OR PRECOMPUTED SINGLE PREDICTION
Numerous tools (Table 1) accept only individual submissions, thereby proving to be inherently unsuitable for the analysis of large sets of variants generated through experiments involving techniques such as next-generation sequencing (NGS), SNP arrays and any form of deep sequencing. The commonly accepted input formats are FASTA protein sequences (plus amino acid positions and wild-type or mutant residues), dbSNP [39] , Uniprot [40] or gene accession numbers [plus information about the genomic regions and multiple sequence alignments (MSAs)]. Only a few websites release a stand-alone version [27, 30, 33] or expose any API or precompiled module for automatic querying of their web servers [37] . These output formats can differ greatly from each another. Apart from the standard outputs (e.g. 'neutral/damaging' or 'affect/ not affect'), most tools provide measures of confidence for each result and, in some instances, information on the disrupted molecular mechanism (e.g. loss of protein thermodynamic stability and loss of functional sites).
These tools make extensive use of machinelearning techniques to safely distinguish neutral from pathogenic variants. 'SNPs&GO' [26] , 'HANSA' [35] , 'LS-SNP' [21] , 'SNPs3D' [22] and 'PhD-SNPs' [30] accept protein sequences in FASTA format or lists of accession numbers (NCBI [29] and 'PMut' [34] , however, achieve the same results by using neural networks. They output a reliability index and a pathogenicity index (both ranging from 0 to 1), respectively, in support of their binary (pathogenic or neutral) predictions. Similarly, 'CanPredict' [31] and 'nsSNPAnalyzer' [32] feed Random Forests with a Gene Ontology similarity score and a curated training set consisting of driver SNPs, respectively, to classify variants with unknown pathogenicity (introduced as FASTA sequences or protein accession numbers) with respect to the degree to which they are likely to be associated with cancer. Alternative methods rely on information about the evolutionary conservation of a DNA sequence mutation to evaluate its disease-causing potential. 'MutationTaster' [33] , 'MutPred' [25] and the 'Panther database' [27] accept input of a coding sequence (open reading frame), a transcript (cDNA sequence) or a gene (genomic sequence). This input is classified as 'silent', 'affecting a single amino acid' or 'causing complex changes in the amino acid sequence' by MutationTaster; as 'disease-associated' or 'neutral' by MutPred; or as 'deleterious' or 'neutral' by the Panther database. In addition to the predictive outcome, the tools generate a probability score regarding whether the prediction is secure, or generate a list of the most affected protein properties. MutationTaster has recently provided several scripts for the submission of batch queries and the analysis of large lists of variants.
'SNPeffect' [19] , 'Hope' [36] , 'Align-GVGD' [28] and 'KD4v' [37] rely on the estimation of the degree of irreversible disruption of structural, geometrical and physicochemical properties and of domain alterations of target proteins, to assess the degree of risk posed by a missense mutation. These tools usually accept FASTA sequences, PDB files, PDB ID or UniProt ID, responding in a binary manner with an output of either 'dangerous' or 'neutral'.
At times, predictions of the potential impact of known missense variants are precomputed, to be used later by third-party software. For example, 'Ensembl' [41] and 'SNPeffect' provide pre-computed SIFT/PolyPhen-2 and SNPeffect (respectively) classifications of missense SNPs that have been published in dbSNP or in other variant databases. In the latest update (October 2012, ver. 2.04) to the 'dbNSFP' database [42] , raw scores from four predictors (SIFT, PolyPhen-2, MutationTaster and MutationAssessor) were cataloged for >80 million variants, along with population genomics data, evolutionary conservation scores and other additional information. It does not have a query interface, but it can be freely downloaded as a bulk file. The 'SNPdbe' web-based resource [42] incorporates precalculated SIFT and SNAP predictions, together with additional annotation levels (e.g. experimentally derived functional and structural impact, predicted functional effect, associated disease, average heterozygosity and evolutionary conservation of wild-type and mutant amino acids), for >155 000 protein sequences derived from >2600 organisms. Overall, this tool references >1 million single amino acid substitutions consisting of natural variants, SAASs from mutagenesis experiments and sequencing conflicts. It accepts the submission of gene/protein symbols, sequences, disease keywords and mutation accession numbers as input. The aforementioned list of programs is certainly not exhaustive. A number of additional yet similar web tools exist, but they unfortunately appear to be offline (e.g. SNPit [43] ) or were no longer updated (e.g. FastSNP [38] ) at this time. Other similar but less updated reviews are available for evaluation [44, 45] .
EVALUATING THE PREDICTION CONGRUENCY FOR REAL EXOMIC DATA
As anticipated, some of the aforementioned tools are capable of simultaneously managing long lists of variants; therefore, they are particularly suited for supporting NGS experiments. Nevertheless, assessment of the pathogenicity of genomic variants is a complex task, particularly owing to the systematic incongruence of the predictions provided by different tools concerning the same variant, an observation published in several previous reports [3] [4] [5] [6] .
As a proof-of-concept investigation, we examined WES data, focusing our attention exclusively on missense SNP classifiers available on the web. Therefore, we submitted our variants' list (as list of tuples of chromosome number, position, reference and alternate allele and strand) to a restricted set of such tools. We primarily considered SIFT 4.0 and PolyPhen-2 2.2.2 web services, as they implement the most popular algorithms for missense SNP pathogenicity assessment. Then, we ran Condel ('was.pl' script) and Carol (http://www.sanger.ac. uk/resources/software/carol/) stand-alone tools on our computing cluster, to obtain consensus predictions of SIFT and PolyPhen-2 outputs. Next, we queried the VEP web service and MutationAssessor through its WebAPI. Table 2 summarizes the aforementioned analyses.
MATERIALS AND METHODS
Our data consist of 2548 high-quality novel missense SNPs, selected from eight different Mendelian disease-associated exomic datasets. These were generated by our SOLiD XL 5500 sequencing platform, which produced 30-40 million reads targeting 50 Mb exonic sites, with an average site coverage of 20-30Â.
Briefly, we aligned exon-enriched DNA reads with the LifeScope TM software (http://www.app liedbiosystems.com/lifescope). Next, we removed duplicate reads by using Picard (http://picard.sour ceforge.net); we calculated the exome coverage through BedTools [47] and recalibrated any poorly aligned reads by GATK [48] . SNPs were called by the GATK and confirmed by using DiBayes and SAMtools [49, 50] . Finally, we annotated variants by ANNOVAR [17] and examined their presence in dbSNP ver. 137 [39] . A more detailed description of this analytical process has been previously reported [51] .
We filtered 300-400 nonsynonymous novel variants from each sample, which we properly formatted for analysis by the selected tools ( Table 2 ). Given that input variants may be mapped on various alternative transcripts and proteins by the different tools, predictions were carefully examined to consider only those performed for the same transcript/protein. Figure 1 shows the results produced by the chosen tools. SIFT and PolyPhen-2 results appear consistent, with $60% of SNPs classified as neutral, whereas 40% classified as damaging ('possibly damaging' and 'probably damaging' in PolyPhen-2). Similar results were given by VEP and MutationAssessor. Contrarily, Condel is in frequent disagreement, namely, it predicts putatively deleterious mutations in excess. Given that we submitted novel (i.e. uncharacterized) nonsynonymous mutations, we cannot say which predictions are true. We aim only at measuring the degree of congruency and consensus among the results of the considered tools.
RESULTS
Owing to the intrinsic diversity of the numerical results of the predictors (different scales and different algorithms), we opted to compare the categorical outcomes. In particular, we assigned mutations a score of 1 when classified as 'neutral' and a score of 2 when classified as 'possibly damaging', 'probably damaging' or 'deleterious'. When an SNP could not be classified, it was assigned a score of 0. Thus, we evaluated the degree of agreement of their results by calculating a 'uniformity score' (us), which is the sum of the scores provided by individual tools for each group. Next, we compared tools as follows: For example, when considering the group 'd' of tools, a score of 6 would indicate that all tools (SIFT, PolyPhen-2, VEP-reporting SIFT scores, VEP-reporting PolyPhen-2) predicted a mutation as 'neutral'. A score of 12 would indicate that the mutation was unanimously predicted as 'deleterious'. Given that PolyPhen-2 categorical predictions are tripartite ('neutral', 'possibly damaging' and 'probably damaging'), the analysis was repeated by only varying the score assigned to the 'possible damaging' result from its original value of 1-2 ( Figure 2A for Analysis 1 and Figure 2B for Analysis 2).
MutationAssessor predictions were grouped as follows: 'Neutral' for 'neutral' and 'low impact' functional scores, and 'Damaging' for 'medium' and 'high' impact functional scores.
For each 'us' value, Figure 2 shows the proportion of mutations in the seven groups.
For both analyses, the number of contrasting predictions between SIFT and PolyPhen-2 (us ¼ 3, group 'a') was around 45%. Congruent classifications, namely, those exhibiting low scores (us ¼ 2), were more commonly observed than high scores (us ¼ 4). This could be due to the fact that predictors tend to be conservative, i.e. they are cautious in classifying an amino acid-changing variant as physiologically damaging. A small portion of our 2.548 novel missense variants (8-15% for Analysis 1 and 2) were classified as damaging from both SIFT and PolyPhen-2. From a biological point of view, it is reasonable to think that most individual missense SNPs (few hundreds on average) are tolerated, while few tens actually affect the organism.
Comparing the derived predictions (Carol and Condel, group 'b', Figure 2 ), we observe a high level of uncertainty, with >70% of the 2.548 predictions being in conflict. Approximately 12-15% of predictions result to be neutral or damaging for both the analyses. Incongruences could depend on the algorithms used to deduce a consensus score from the original prediction of SIFT and PolyPhen-2. Interestingly, most conflicts seem to occur whenever SIFT and PolyPhen-2 deliberate a neutral prediction (us ¼ 2). Thus, researchers should be aware that consensus algorithms may yield results that substantially contrast the predictions that they derive from. When we compared predictions and derived predictions of neutrality by SIFT, PolyPhen-2 and one of the two consensus algorithms in turn (Figures 2, group 'c', us ¼ 5), we found that 83.8 and 74.6% (Analysis 1 and 2, respectively) of discordant predictions were yielded by Condel runs. In addition, we studied individual conflicts, occurring when single predictors are in disagreement. Again, in absence of any experimental confirmation, discordant predictions could be right.
Consequently, we examined the degree of congruency among SIFT, PolyPhen-2 and VEP predictions, still considering predictions with us ¼ 5 (mutations classified as neutral by all but one tool) and us ¼ 7 (i.e. all tools but one predict mutation as 'damaging'). Proportions of 'us' are shown in group 'd' in Figure 2 . While SIFT and VEP-SIFT predictions are concordant, differences emerge between PolyPhen-2 and VEP-PolyPhen-2. PolyPhen-2 yields the highest percentage of discordant classifications (50% and 80% of variants exhibit an us ¼ 5 and us ¼ 7, respectively). A similar trend was observed in Analysis 2, with PolyPhen-2 predictions constituting 60% and 76% of the total number of incongruent results. The output of VEP-PolyPhen-2 is in substantial agreement with those of SIFT and VEP-SIFT. Differences could be due to the database version from which the predictor is trained. Thus, predictions should be treated with caution whenever they come from a third-party web service.
Then, we compared SIFT, PolyPhen-2, derived Condel and Carol consensus outputs and VEP. Classifications generating a 'us' of 7 or 11 were taken into consideration (a score of 7 is obtained from the agreement of 5 tools on the neutrality of a variant, whereas a score of 11 results from a partial consensus over a pathogenic effect). Condel and PolyPhen-2 were almost equally discordant (50% in Analysis 1 and 85% in Analysis 2 of discordance for variants with us ¼ 7 and us ¼ 11). Finally, we tested the congruency of tools belonging to group 'f', by considering variants with us ¼ 6 and us ¼ 9. PolyPhen-2 seemed to be mostly discordant, whereas SIFT, VEP-SIFT, VEP-PolyPhen-2 and MutationAssessor gave consistent outcomes (in both analyses; Figure 2 ).
In conclusion, we evaluated all tools together (group 'g') and looked at variants with us ¼ 8, which are obtained whenever one gets a singular prediction of dangerousness against a consensus of neutrality, and us ¼ 13. Condel resulted to be the most incongruent predictor. It is responsible for $60% of us ¼ 8 (all neutral but one) and us ¼ 13 (all damaging but one) predictions.
CONCLUSION
Evaluation of the functional impact of nonsynonymous variants is an important step in the process of searching for disease-causing mutations. Bioinformatics tools provide several relatively rapid procedures for classifying and prioritizing massive sets of candidate variants before resorting to expensive and labor-intensive functional assays. However, such methods present several fundamental limitations:
Differences in methods, reference databases, training datasets and alignment algorithms may lead to conflicting results. Data are generated in varying and often incompatible formats that often cannot be automatically parsed because they are not textual. Several tools are no longer maintained or are rarely updated.
The features and performances of many SNP functional predictors have been previously evaluated; SNPs&GO and MutPred were considered superior in terms of 'statistical accuracy', whereas their 'sensitivity' was indeterminate [3] . SIFT, PolyPhen-2 and nsSNP-Analyzer were determined to be the optimum predictive methods in a comparative study based on functional assays of several different mutant forms of a human enzyme [4] . Predictions were also determined to be congruent in another comparative study regarding a human protein carrier [5] , but were found to be incongruent and dependent on the alignment algorithms used in a third study [6] .
Our work does not provide a systematic comparison among these tools nor a statistical view of their performance. Rather, it highlights the degree of uniformity of their predictions. Specifically, our experience and the results of this brief study suggest that when using the most popular SIFT and PolyPhen-2 web tools, a remarkably high proportion of the obtained predictions are contrasting. While a consensus-based strategy should confer more reliability to results, here we find the other way around. Condel is responsible of most of the conflicts, as it contradicts the other tools whenever they agree on neutrality. Furthermore, conflicts could also arise when using the same (i.e. identical software version) integrated third-party predictor by different web services, as we experienced when we queried SIFT and PolyPhen-2 from VEP.
Again, our analyses take into account the degree of uniformity among the various predictors, rather than their effectiveness. Discordant predictions have been calculated only when all tools (except for one) generated uniform results, with the awareness that any discordant prediction carries a probability of being the true-positive result. Unfortunately, testing in vitro the functional impact of missense SNPs is not feasible (in terms of cost and time), given the high number of possible candidate variants that are routinely generated by NGS experiments.
For large lists of missense mutations, we recommend the use of PolyPhen-2 and SIFT web-based tools because they are well suited for NGS-derived data, in terms of both computing times and frequency of updates. Nonetheless, in the case of contrasting outcomes, the use of Carol is desirable. Given that an elevated number of variants could still be uncertainly classified, other tools could be queried. In the particular case in which one considers a few missense variants, SNPs&GO, SNPeffect and MutPred tools could give a valuable support.
The tools described in this review use different sources of information and classification methods to infer the physiological impact of missense mutations. Methodologies are continuously being developed and refined as new information about phenotype/ genotype correlations, protein structures, orthologous sequences and protein functions is acquired. For example, WES will detect thousands of homozygous and heterozygous missense mutations, while tens or hundreds of these could be classified as theoretically damaging but practically harmless owing to the complex compensatory mechanisms within the cell. Data from the 1000 Genomes Project showed that mutations with mildly deleterious effects are generally frequent in human populations [52] and determine factors such as complex disease susceptibility and drug sensitivity, whereas high-impact mutations are rare and constitute the genetic roots of Mendelian diseases [2] .
Predicting the effect of a missense mutation in light of the presence of other variants within a protein or its 'interactome' (i.e. set of interacting proteins) is an innovative but complex challenge. This is true simply because we are far from obtaining a complete understanding of protein-protein interactions, structural/functional properties of protein complexes or coevolution among protein-encoding genes. We can hypothesize that coevolving sites among genes could guarantee protein functionality, e.g. a mutation in protein 'A', classified as 'deleterious', could be practically 'neutralized' if a specific variant appears in the interacting protein 'B'. If this variant is not present, the effect of mutation 'A' should be deleterious.
New classification methods could improve predictions by evaluating the impact of variants on interacting proteins. The lack of compensatory mutations, in addition to factors such as sequence conservation, structural modification and gene ontologies, could contribute to improved classification of mutations. Mutations that completely escape from this compensatory genetic background (e.g. individual or familial mutations) could likely be associated with disease.
Key points
Missense mutations constitute a potential source of disease, disease susceptibility and drug sensitivity. Several algorithms and tools for functional classification of missense mutations have been developed. Sequence conservation and structural modifications are the primary elements from which pathological consequences are inferred. Performance and range of applicability vary among the different tools. 
